Search Prime Grants

W81XWH2210372

Project Grant

Overview

Grant Description
Combinatorial helper-dependent adenoviral gene therapy for post-traumatic osteoarthritis.
Awardee
Baylor College Of Medicine
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Funding Agency
Medical Command (MEDCOM) [DoD - USA]
Place of Performance
Houston, Texas 770303411 United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH21PRMRPTTDA
Baylor College Of Medicine was awarded Combinatorial HDAd Gene Therapy for PTOA Project Grant W81XWH2210372 worth $5,043,776 from Medical Command in July 2022 with work to be completed primarily in Houston Texas United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 6/27/22

Period of Performance
7/1/22
Start Date
6/30/26
End Date
79.0% Complete

Funding Split
$5.0M
Federal Obligation
$0.0
Non-Federal Obligation
$5.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2210372

Subgrant Awards

Disclosed subgrants for W81XWH2210372

Additional Detail

Award ID FAIN
W81XWH2210372
SAI Number
None
Award ID URI
None
Awardee Classifications
Private Institution Of Higher Education
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
FXKMA43NTV21
Awardee CAGE
9Z482
Performance District
09
Senators
John Cornyn
Ted Cruz
Representative
Al Green
Modified: 6/27/22